Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2022-03-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
第四届董事会第三十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by Tianjin Ruipu Biotechnology Co., Ltd. It details the approval of a proposal regarding the continued use of idle funds to purchase financial products. The text includes meeting attendance, voting results, and references to independent directors' opinions and disclosures on a regulatory website. There is no financial statement or detailed report content, but rather a corporate governance announcement about board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2022-03-14 Chinese
关于变更签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding a change in the signing certified public accountant (CPA) for the company's 2021 financial audit. It details the replacement of one signing CPA with another, provides background on the new CPA, and confirms no impact on the audit work. The document is short (1365 characters) and does not contain any financial statements or substantive financial data. It is not the audit report itself but an announcement about a change related to the audit process. Therefore, it fits the category of Audit Report / Information (AR), which includes standalone audit reports and related information such as changes in auditors or signing accountants. FY 2021
2022-03-02 Chinese
关于股东股份质押的补充更正公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the correction and supplementation of information about shareholder stock pledges. It details the number of shares pledged by a shareholder, the pledge terms, and reassures about the risk and impact on the company. There is no financial report, earnings data, or management discussion. The document is short (1650 characters) and serves as a regulatory disclosure about share pledging, which is a typical regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. Therefore, it best fits the Regulatory Filings (RNS) category, which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-02-24 Chinese
关于取得兽药产品批准文号的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1300 characters) from Tianjin Ruipu Biotechnology Co., Ltd. about obtaining an approval number for a veterinary drug product (a recombinant avian influenza vaccine). It contains no financial data, no discussion of financial results, no management commentary, and no regulatory form references. It is clearly an announcement of a product approval, not a financial report or meeting material. The document length and content indicate it is not a report but a regulatory announcement about product approval. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-02-22 Chinese
关于股东股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the pledge of shares by a shareholder holding more than 5% of the company's shares. It details the number of shares pledged, pledge start and end dates, pledgee, and the proportion of shares pledged relative to the shareholder's holdings and the company's total share capital. The document also states the shareholder's credit status and the impact of the pledge on the company. This is a typical announcement about shareholder share pledging activity, which relates to changes in share ownership or encumbrances but does not constitute a full financial report or earnings release. It is not a report publication announcement or regulatory filing in the sense of officer certifications or compliance documents. The document is short (1284 characters) and focused on share pledge information. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or related shareholding events such as pledges.
2022-02-15 Chinese
关于获得发明专利的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (786 characters) about the company obtaining invention patents. It includes patent details and emphasizes the impact on the company's innovation and operations. There is no financial data, no mention of financial results, no regulatory filings, or meeting materials. It is not a report or a certification but a corporate announcement about intellectual property. This type of document does not fit into financial reports or regulatory filings categories but is a general corporate announcement. Given the provided categories, the closest fit is Regulatory Filings (RNS) as a fallback for miscellaneous announcements that do not fit other categories.
2022-02-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.